Oligodendrocyte Precursor Cells Support Blood-Brain Barrier Integrity via TGF-β Signaling

• Ji Hae Seo ,

  Contributed equally to this work with: Ji Hae Seo, Takakuni Maki

  Affiliations Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, United States of America, SNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea

  ⨯
• Takakuni Maki ,

  Contributed equally to this work with: Ji Hae Seo, Takakuni Maki

  Affiliation Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, United States of America

  ⨯
• Mitsuyo Maeda,

  Affiliations Department of Anatomy, Osaka Dental University, Osaka, Japan, Department of Regenerative Medicine, Institute of Biomedical Research and Innovation, Kobe, Japan

  ⨯
• Nobukazu Miyamoto,

  Affiliation Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, United States of America

  ⨯
• Anna C. Liang,

  Affiliation Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, United States of America

  ⨯
• Kazuhide Hayakawa,

  Affiliation Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, United States of America

  ⨯
• Loc-Duyen D. Pham,

  Affiliation Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, United States of America

  ⨯
• Fumihiko Suwa,

  Affiliation Department of Anatomy, Osaka Dental University, Osaka, Japan

  ⨯
• Akihiko Taguchi,

  Affiliation Department of Regenerative Medicine, Institute of Biomedical Research and Innovation, Kobe, Japan

  ⨯
• Tomohiro Matsuyama,

  Affiliation Laboratory of Neurogenesis and CNS Repair, Institute for Advanced Medical Science, Hyogo College of Medicine, Hyogo, Japan

  ⨯
• Masafumi Ihara,

  Affiliation Department of Stroke and Cerebrovascular Diseases, National Cerebral and Cardiovascular Center, Osaka, Japan

  ⨯
• Kyu-Won Kim,

  Affiliations SNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea, Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul National University, Seoul, Korea

  ⨯
• Eng H. Lo ,

  * E-mail: karai@partners.org (KA); lo@helix.mgh.harvard.edu (EHL)

  Affiliation Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, United States of America

  ⨯
• Ken Arai

  * E-mail: karai@partners.org (KA); lo@helix.mgh.harvard.edu (EHL)

  Affiliation Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, United States of America

  ⨯